Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-21-000008

Chief Executive Officer sold 162,500 shares at an average $14.71 ($2,390,000)

  • Chief Executive Officer acquired 62,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kim Jong Joseph · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Sale : show line 1 in the form −100,000 $15.00 $1,500,000 1,078,313 D
2021-02-03 Exercise or conversion : show line 2 in the form +62,500 $4.56 $285,000 1,140,813 D
2021-02-03 Sale : show line 3 in the form −62,500 $14.24 $890,000 1,078,313 D
Open-market sales · 162,500 sh · avg $14.71 · $2,390,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-03 Exercise or conversion : show line 4 in the form Common Stock Option −62,500 0 D
Loading xslF345X03/wf-form4_161239761257738.xml…